HU9502198D0 - Novel indication - Google Patents

Novel indication

Info

Publication number
HU9502198D0
HU9502198D0 HU9502198A HU9502198A HU9502198D0 HU 9502198 D0 HU9502198 D0 HU 9502198D0 HU 9502198 A HU9502198 A HU 9502198A HU 9502198 A HU9502198 A HU 9502198A HU 9502198 D0 HU9502198 D0 HU 9502198D0
Authority
HU
Hungary
Prior art keywords
novel indication
indication
novel
Prior art date
Application number
HU9502198A
Other languages
English (en)
Inventor
Kovacs Attila B
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Priority to HU9502198A priority Critical patent/HU9502198D0/hu
Publication of HU9502198D0 publication Critical patent/HU9502198D0/hu
Priority to EP96923004A priority patent/EP0841915A1/en
Priority to PL96324460A priority patent/PL324460A1/xx
Priority to PCT/HU1996/000038 priority patent/WO1997003664A1/en
Priority to EA199800146A priority patent/EA199800146A1/ru
Priority to CZ9827A priority patent/CZ2798A3/cs
Priority to AU63670/96A priority patent/AU6367096A/en
Priority to KR1019980700235A priority patent/KR19990028933A/ko
Priority to JP50646497A priority patent/JP2001503371A/ja
Priority to EE9800020A priority patent/EE9800020A/xx
Priority to CN96195722A priority patent/CN1191483A/zh
Priority to IL12275196A priority patent/IL122751A0/xx
Priority to MX9800603A priority patent/MX9800603A/es
Priority to SK32-98A priority patent/SK3298A3/sk
Priority to CA002227421A priority patent/CA2227421A1/en
Priority to BR9610187A priority patent/BR9610187A/pt
Priority to ZA9606079A priority patent/ZA966079B/xx
Priority to HRP9502198A priority patent/HRP960345A2/hr
Priority to YU42796A priority patent/YU42796A/sh
Priority to ARP960103677A priority patent/AR002905A1/es
Priority to NO980127A priority patent/NO980127L/no
Priority to BG102182A priority patent/BG102182A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
HU9502198A 1995-07-21 1995-07-21 Novel indication HU9502198D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication
BR9610187A BR9610187A (pt) 1995-07-21 1996-07-16 Uso de ipriflavona para reduzir o número de células cd8+
CN96195722A CN1191483A (zh) 1995-07-21 1996-07-16 异丙氧基异黄酮在减少cd8+细胞数量中的应用
MX9800603A MX9800603A (es) 1995-07-21 1996-07-16 Uso de la ipriflavona para reducir el numero de celulas cd8+.
PCT/HU1996/000038 WO1997003664A1 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells
EA199800146A EA199800146A1 (ru) 1995-07-21 1996-07-16 Использование иприфлавона для понижения числа cd8+ клеток
CZ9827A CZ2798A3 (cs) 1995-07-21 1996-07-16 Farmaceutický přípravek schopný snížit počet CD8+buněk
AU63670/96A AU6367096A (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells
KR1019980700235A KR19990028933A (ko) 1995-07-21 1996-07-16 이프리플라본을 사용하여 cd8+세포의 수를 감소시키는방법
JP50646497A JP2001503371A (ja) 1995-07-21 1996-07-16 Ｃｄ８＋細胞の個数を減少させるイプリフラボンの使用
EE9800020A EE9800020A (et) 1995-07-21 1996-07-16 Ipriflavooni kasutamine CD8+ rakkude arvu vähendamiseks
EP96923004A EP0841915A1 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells
IL12275196A IL122751A0 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of CD8 + cells
PL96324460A PL324460A1 (en) 1995-07-21 1996-07-16 Application of ipiflavone for reducing numbger of cd8+ cells
SK32-98A SK3298A3 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells
CA002227421A CA2227421A1 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells
ZA9606079A ZA966079B (en) 1995-07-21 1996-07-17 New indication.
HRP9502198A HRP960345A2 (en) 1995-07-21 1996-07-18 Use of ipriflavone to reduce the number of cd8+ cells
YU42796A YU42796A (sh) 1995-07-21 1996-07-19 Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija
ARP960103677A AR002905A1 (es) 1995-07-21 1996-07-22 Composiciones farmaceuticas, apropiadas para hacer disminuir la cantidad de celulas cd8+
NO980127A NO980127L (no) 1995-07-21 1998-01-12 Anvendelse av ipriflavon for å redusere antall CD8+ celler
BG102182A BG102182A (en) 1995-07-21 1998-01-14 The use of ipriflavon for reducing the number of cd8+ cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication

Publications (1)

Publication Number Publication Date
HU9502198D0 true HU9502198D0 (en) 1995-09-28

Family

ID=10987063

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication

Country Status (22)

Country Link
EP (1) EP0841915A1 (hu)
JP (1) JP2001503371A (hu)
KR (1) KR19990028933A (hu)
CN (1) CN1191483A (hu)
AR (1) AR002905A1 (hu)
AU (1) AU6367096A (hu)
BG (1) BG102182A (hu)
BR (1) BR9610187A (hu)
CA (1) CA2227421A1 (hu)
CZ (1) CZ2798A3 (hu)
EA (1) EA199800146A1 (hu)
EE (1) EE9800020A (hu)
HR (1) HRP960345A2 (hu)
HU (1) HU9502198D0 (hu)
IL (1) IL122751A0 (hu)
MX (1) MX9800603A (hu)
NO (1) NO980127L (hu)
PL (1) PL324460A1 (hu)
SK (1) SK3298A3 (hu)
WO (1) WO1997003664A1 (hu)
YU (1) YU42796A (hu)
ZA (1) ZA966079B (hu)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (it) * 1990-03-23 1993-12-29 Chiesi Farma Spa Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Also Published As

Publication number Publication date
HRP960345A2 (en) 1998-02-28
IL122751A0 (en) 1998-08-16
EE9800020A (et) 1998-08-17
BG102182A (en) 1998-08-31
NO980127D0 (no) 1998-01-12
EP0841915A1 (en) 1998-05-20
PL324460A1 (en) 1998-05-25
CZ2798A3 (cs) 1998-06-17
MX9800603A (es) 1998-04-30
KR19990028933A (ko) 1999-04-15
AR002905A1 (es) 1998-04-29
SK3298A3 (en) 1998-07-08
JP2001503371A (ja) 2001-03-13
NO980127L (no) 1998-01-12
EA199800146A1 (ru) 1998-08-27
CN1191483A (zh) 1998-08-26
YU42796A (sh) 1999-03-04
WO1997003664A8 (en) 1999-08-05
WO1997003664A1 (en) 1997-02-06
AU6367096A (en) 1997-02-18
CA2227421A1 (en) 1997-02-06
ZA966079B (en) 1998-01-19
BR9610187A (pt) 1998-07-28

Similar Documents

Publication Publication Date Title
ZA968451B (en) Novel sulfonylaminopyrimidines
ZA96237B (en) Substituted 2-pheylpyridines
DE59602888D1 (en) Breitstreckaggregat
EP0858063A4 (en) COLORED INDICATOR
ZA96238B (en) Substituted 2-pheylpyridines
DE59602283D1 (en) Inchbremseinrichtung
DE59602030D1 (en) Zellige polyurethan-elastomere
DE59505396D1 (en) Handhobelmaschine
HK1016175A1 (en) Substituted phenyluracils
AP9600802A0 (en) Libricant
DE59600830D1 (en) Breitstrahldüse
DE59604506D1 (en) Rückkühlsystem
AU127338S (en) Scale
GB9506678D0 (en) Substituted 6-azacholesten-3-ones
SG72612A1 (en) Substituted azo-dicarbonylo derivatites
GB2299858B (en) Indicator
HU9502198D0 (en) Novel indication
AU1105P (en) DALESE Metrosideros excelsus
GB9503206D0 (en) Novel use
ZA9610716B (en) New herbicidees
GB9517905D0 (en) Improved can
HU9500171V0 (en) Wood- dave ment
PL103582U1 (en) Overall
AU125129S (en) Quiltcover
AU125678S (en) Sandboard